Lactobacillus delbrueckii subsp lactis (strain CIDCA 133) resists the antimicrobial activity triggered by molecules derived from enterocyte-like Caco-2 cells

Letters in Applied Microbiology

Volumn 50, Issue 4, 2010, Pages 335-340

  Hugo, A A ^a   De Antoni, G L ^a,b   Perez P F ^a,b  

^a CENTRO DE INVESTIGACIÓN Y DESARROLLO EN CRIOTECNOLOGÍA DE ALIMENTOS CIDCA   (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

Cationic peptides; Defensins; Innate host defence; Lactobacilli; Probiotics

Indexed keywords

BACTERIA; BACTERIOLOGY; DRUG INTERACTIONS; GROWTH KINETICS; MOLECULES; PEPTIDES; RESINS;

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL PEPTIDE; BATCH EXTRACTION; CACO-2 CELLS; CATION EXCHANGE RESINS; CATIONIC FRACTION; CATIONIC PEPTIDES; CYTOSOLIC; CYTOSOLIC FRACTIONS; DEFENSINS; ENTEROCYTES; GRAM-NEGATIVE BACTERIA; IMMUNE SYSTEMS; IN-VITRO; LACTOBACILLUS DELBRUECKII; PROBIOTIC STRAIN; PROBIOTICS; SELECTION CRITERIA; VIABLE COUNT;

STRAIN;

CATION EXCHANGE RESIN; DEFENSIN; PROBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; BACTERIUM; IMMUNE SYSTEM; PEPTIDE; PROBIOTICS;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL GROWTH; CELL STRAIN CACO 2; CYTOSOL; DIFFUSION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTESTINE CELL; LACTOBACILLUS DELBRUECKII; NONHUMAN;

LACTOBACILLUS DELBRUECKII; NEGIBACTERIA; POSIBACTERIA;

EID: 77949377746     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2010.02796.x     Document Type: Article

References (25)

1. Bernet-Camard, M.F., Coconnier, M.H., Hudault, S. and Servin, A.L. (1996) Differentiation-associated antimicrobial functions in human colon adenocarcinoma cell lines. Exp Cell Res 226, 80-89.
2. Brogden, K.A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3, 238-250.
3. Fuller, R.. (1989) Probiotics in man and animals. J Appl Bateriol 66, 365-378.
4. Ganz, T. (2002) Ephitelia: not just physical barriers. Proc Natl Acad Sci 99, 3357-3358.
5. Gómez Zavaglia, A., Disalvo, E.A. and De Antoni, G.L. (2000) Fatty acid composition and freeze-thaw resistance in lactobacilli. J Dairy Res 67, 241-247.
6. Hancock, R.E. and Rozek, A. (2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 206, 143-149.
7. Hecht, G. (1999) Innate mechanisms of epithelial host defense: spotlight on intestine. Am J Physiol 277, 351-358.
8. Hord, N.G. (2008) Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics. Annu Rev Nutr 28, 215-231.
9. Hugo, A.A., De Antoni, G.L. and Pérez, P.F. (2006) Lactobacillus delbrueckii subsp lactis strain CIDCA 133 inhibits nitrate reductase activity of E. coli. Int J Food Microbiol 111, 191-196.
10. Hugo, A.A., Kakisu, E.J., De Antoni, G.L. and Pérez, P.F. (2008) Lactobacilli antagonize biological effects of enterohaemorrhagic Escherichia coli in vitro. Lett Appl Microbiol 46, 613-619.
11. Jenssen, H., Hamill, P. and Hancock, R.E. (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19, 491-511.
12. Klaenhammer, T.R. and Kullen, M.J. (1999) Selection and design of probiotics. Int J Food Microbiol 50, 45-57.
13. Lehrer, R.I., Rosenman, M., Harwig, S.S., Jackson, R. and Eisenhauer, P. (1991) Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 137, 167-173.
14. Liévin-Le Moal, V. and Servin, A.L. (2006) The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 19, 315-337.
15. Mishra, V. and Prasad, D.N. (2005) Aplication of in vitro methods for selection of Lactobacillus casei strains as potential probiotics. Int J Food Microbiol 103, 109-115.
16. Möndel, M., Schroeder, B.O., Zimmermann, K., Huber, H., Nuding, S., Beisner, J., Fellermann, K., Stange, E.F. et al. (2009) Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2, 166-172.
17. Peschel, A. (2002) How do bacteria resist human antimicrobiol peptides? Trends Microbiol 10, 179-186.
18. Pinto, M., Robine-Leon, S., Appay, M., Kedinger, M., Triadou, N., Dussaulx, E., Lacroix, B., Simmon-Assmann, P. et al. (1983) Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Bio Cell 47, 323-330.
19. Porter, E.M., Poles, M.A., Lee, J.S., Naitoh, J., Bevins, C.L. and Ganz, T. (1998) Isolation of human intestinal defensins from ileal neoblader urine. FEBS Lett 434, 272-276.
20. Rose, F.R.A.J., Bailey, K., Keyte, J.W., Chan, W.C., Greenwood, D. and Mahida, Y.R. (1998) Potential role of epithelial cell-derived histone H1 proteins in innate antimicrobial defense in the human gastrointestinal tract. Infect Immun 66, 3255-3263.
21. Salzman, N.H., Underwood, M.A. and Bevins, C.L. (2007) Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 19, 70-83.
22. Saxelin, M., Tynkkynen, S., Mattila-Sandholm, T. and de Vos, W.M. (2005) Probiotics and other functional microbes: from markets to mechanisms. Curr Opin Biotech 16, 204-211.
23. Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T.A., Stange, E.F. and Fellermann, K. (2007) Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun 75, 2399-23407.
24. Schlee, M., Harder, J., Köten, B., Stange, E.F., Wehkamp, J. and Fellermann, K. (2008) Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immuno 151, 528-535.
25. Yanagi, S., Ashitani, J., Imai, K., Kyoraku, Y., Sano, A., Matsumoto, N. and Nakazato, M. (2007) Significance of human beta-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections. Clin Microbiol Infect 13, 63-69.